{"id":1178670,"name":"Alnylam Pharmaceuticals Inc","transferAgent":{"dtcMemberId":null,"name":"Equiserve Trust Company, N.A."},"allClaimedTransferAgents":[{"dtcMemberId":null,"name":"Equiserve Trust Company, N.A.","asOfDate":{"value":"2020-12-17"},"docUrl":"https://www.nasdaqtrader.com/content/home/help/samplereports/Fundamental_Data_cusip121720.xlsx"}],"tickers":[{"ticker":"ALNY","exchange":"Nasdaq","description":"Common Stock","hasOnlinePurchase":null,"cusip":"02043Q107"}],"holders":{"filingDate":{"value":"2022-02-10"},"totalHolders":24,"docUrls":["1178670/000117867022000013/alny-20211231.htm"]}}